Leerink Partnrs Forecasts Lower Earnings for AstraZeneca
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities researchers at Leerink Partnrs lowered their FY2024 earnings estimates for shares of AstraZeneca in a research note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings per share of $4.13 for the year, down from their […]
![Leerink Partnrs Forecasts Lower Earnings for AstraZeneca](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/astrazeneca-plc-logo-1200x675.png?v=20231213131257&w=240&h=240&zc=2)